XBiotech Inc. (XBIT)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

2.29 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2023, ended 31 Dec 2023, as filed

Revenue

$0.00

Net income

$24.56M

Free cash flow

$19.09M

Return on equity

-11.2%

Return on capital

-13.5%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
18 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$431.25K	0.9%
15 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$226.47K	0.4%
14 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$272.52K	0.5%
13 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$139.53K	0.3%
12 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$229.94K	0.5%
7 Oct 2021	SIMARD JOHN Chief Executive Officer	Sold, plan not stated	$489.11K	1.0%

31out of 100

Profitability 6

Financial strength 75

Growth 0

Insiders 50

Strongest on financial strength (75), weakest on growth (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan